BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15843019)

  • 1. Local RNA target structure influences siRNA efficacy: a systematic global analysis.
    Overhoff M; Alken M; Far RK; Lemaitre M; Lebleu B; Sczakiel G; Robbins I
    J Mol Biol; 2005 May; 348(4):871-81. PubMed ID: 15843019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions.
    Schubert S; Grünweller A; Erdmann VA; Kurreck J
    J Mol Biol; 2005 May; 348(4):883-93. PubMed ID: 15843020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
    Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
    Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic analysis of the effect of target RNA structure on RNA interference.
    Westerhout EM; Berkhout B
    Nucleic Acids Res; 2007; 35(13):4322-30. PubMed ID: 17576691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.
    Vankoningsloo S; de Longueville F; Evrard S; Rahier P; Houbion A; Fattaccioli A; Gastellier M; Remacle J; Raes M; Renard P; Arnould T
    FEBS J; 2008 Jun; 275(11):2738-53. PubMed ID: 18422646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of target site accessibility on the design of effective siRNAs.
    Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL
    Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structure-activity relationship study of siRNAs with structural variations.
    Chang CI; Hong SW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2007 Aug; 359(4):997-1003. PubMed ID: 17577577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region.
    Luo KQ; Chang DC
    Biochem Biophys Res Commun; 2004 May; 318(1):303-10. PubMed ID: 15110788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production.
    Li G; Li D; Xie Q; Shi Y; Jiang S; Jin Y
    J Gene Med; 2008 Sep; 10(9):1039-47. PubMed ID: 18613219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the efficiency of a siRNA directed against MDR1 expression in MCF7-R cells when combined with a second siRNA.
    Stierlé V; Laigle A; Jollès B
    Biochimie; 2007 Aug; 89(8):1033-6. PubMed ID: 17459558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positional effects and strand preference of RNA interference against hepatitis C virus target sequences.
    Smith RM; Smolic R; Volarevic M; Wu GY
    J Viral Hepat; 2007 Mar; 14(3):194-212. PubMed ID: 17305886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational models with thermodynamic and composition features improve siRNA design.
    Shabalina SA; Spiridonov AN; Ogurtsov AY
    BMC Bioinformatics; 2006 Feb; 7():65. PubMed ID: 16472402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting RNA-interference pathway with small molecules.
    Chiu YL; Dinesh CU; Chu CY; Ali A; Brown KM; Cao H; Rana TM
    Chem Biol; 2005 Jun; 12(6):643-8. PubMed ID: 15975509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides.
    Kretschmer-Kazemi Far R; Sczakiel G
    Nucleic Acids Res; 2003 Aug; 31(15):4417-24. PubMed ID: 12888501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of siRNA in mammalian cells is related to the kinetics of siRNA-target recognition in vitro: mechanistic implications.
    Wünsche W; Sczakiel G
    J Mol Biol; 2005 Jan; 345(2):203-9. PubMed ID: 15571715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.
    Du Q; Thonberg H; Wang J; Wahlestedt C; Liang Z
    Nucleic Acids Res; 2005; 33(5):1671-7. PubMed ID: 15781493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
    Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
    J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human metapneumovirus replication by small interfering RNA.
    Deffrasnes C; Cavanagh MH; Goyette N; Cui K; Ge Q; Seth S; Templin MV; Quay SC; Johnson PH; Boivin G
    Antivir Ther; 2008; 13(6):821-32. PubMed ID: 18839783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential design rules and enzymatic synthesis of siRNAs.
    Sioud M; Leirdal M
    Methods Mol Biol; 2004; 252():457-69. PubMed ID: 15017071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Many commonly used siRNAs risk off-target activity.
    Snøve O; Holen T
    Biochem Biophys Res Commun; 2004 Jun; 319(1):256-63. PubMed ID: 15158470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.